International Journal of Cardiology

Article	Citations
Admission and discharge sodium: Chloride ratio in acute heart failure – The importance of electrolytes	129
Three-dimensional echocardiography reveals early mitral valve alterations in hypertrophic cardiomyopathy genetic mutation carriers	85
Sex differences outcomes in conduction system pacing for patients with typical left bundle branch block	73
Drug-induced increase in dispersion of ventricular repolarization in patients with heart failure with preserved ejection fraction	70
The axillary vein puncture for implantable cardiac defibrillator implantation: 14 years of experience. Analysis of the results	61
Patterns of atrial fibrillation, relevant cardiac structural and functional changes predict functional and cognitive outcomes in patients with ischemic stroke and atrial fibrillation	59
Mitral valve reoperation: Refining risk stratification for better outcomes	58
Signature of standard modifiable CV factors as unrecognizable risk factor of in-hospital mortality in patients with acute myocardial infarction	58
Sudden death of an athlete with concealed arrhythmogenic cardiomyopathy	57
Contemporary outcomes of surgical aortic valve replacement in patients referred for a transcatheter approach	56
Using machine learning to guide imaging in hypertrophic cardiomyopathy - from lessening the burden of our day-to-day clinical decisions to more cost-effective resource utilization	55
The association of bisphosphonates, calcium levels and PTH levels with bioprosthetic aortic valve degeneration	50
Impact of veno-venous collaterals on outcome after the total cavopulmonary connection	47
Prognostic value of exercise tolerance and exercise-induced diastolic dysfunction in elderly patients referred for exercise stress echocardiography	47
Left ventricular diastolic dysfunction in patients with heart failure with mildly reduced ejection fraction	46
Letter to the editor: Duration of atrial fibrillation and cardiac biomarkers are associated with cardiovascular outcomes in early permanent atrial fibrillation: Data from the RACE II study	46
Response to the letter to the editor regarding “Changes in syndecan-1 concentration in the coronary sinus immediately after cardiac reperfusion reflect postoperative myocardial injury”	45
Reply to “Tertiary-centric data and AMI-CS care: Does it reflect real-world adherence?”	44
Downstream cangrelor versus upstream ticagrelor in patients with ST-segment elevation myocardial infarction: A propensity score-matched analysis	43
Letter to “Trajectory, correlates, and outcomes of pulmonary congestion by lung ultrasound in patients hospitalized for acute pulmonary edema”	43
Fibroblast growth factor 5 as a target for atrial fibrillation treatment: Evidence from mendelian randomization	43
Corrigendum to “Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis” [International Journal of Cardiology Volume 357, 15 June 2022, Pages 88–94].	41
Non-hyperemic, non pressure wire, coronary physiology. A further step towards the generalization of physiology in the cath-lab?	40
Perspectives in noninvasive imaging for chronic coronary syndromes	40
Levosimendan versus dobutamine in acute heart failure: Insight into short and long term mortality	39

Anticoagulation control in Malaysia: Reports of time in therapeutic range, bleeding, and thromboembolic complications	39
The total thrombus-formation analysis system in infective endocarditis patients undergoing valve replacement: Does it have predictive value?	38
Frailty in acute coronary syndromes. A systematic review and narrative synthesis of frailty assessment tools and interventions from randomised controlled trials	37
Female, the dominant gender– a study of the Serdang Pulmonary Hypertension Registry	37
Circulating progenitor cells and outcomes in patients with coronary artery disease	36
Elevated lipoprotein (a) another significant predictor of first-onset myocardial infarction among Malaysian adults	36
Potential mechanisms uncovered for the cardioprotective effects of high-intensity interval training	36
Indications, implications and safety of cardiovascular magnetic resonance (CMR) imaging in Malaysian population from the Multicentre Malaysian CMR Registry	35
P 013: Purulent pericardial effusion: A rare and silent life-threatening disease	34
Comparative efficacy of vericiguat to sacubitril/valsartan for patients with heart failure reduced ejection fraction: Systematic review and network meta-analysis	33
Association between QRS shortening and mortality after cardiac resynchronization therapy: Results from the DANISH study	33
Myocardial infarction with no obstructive coronary artery (MINOCA): Prevalence, demographic pattern and 1-month outcome from Serdang PPCI STEMI Registry over 7 years	32
Corrigendum to “Molecular genetic testing in athletes: Why and when a position statement from the Italian Society of Sports Cardiology” [International Journal of Cardiology Volume 364, 1 October 2022,	32
Spontaneous coronary artery dissection: A look back to build momentum	32
Heart failure management guided by remote multiparameter monitoring: A meta-analysis	32
Can cuproptosis-related genes be involved in the pathogenesis of dilated cardiomyopathy?	31
TASH Two TASH	31
WITHDRAWN: Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension: A systematic review and network meta-analysis	31
Inflammation in chronic kidney disease – Something old, something new	31
P 032: Acute ruptured chordae tendinea in infective endocarditis	31
Aortic root/left ventricular diameters golden ratio in competitive athletes	31
Sex-related differences among young adults with heart failure: Does sex matter?	30
Direct oral anticoagulants versus percutaneous left atrial appendage occlusion in atrial fibrillation: 5-year outcomes	29
The effects of Thrombospondin-1 on cardiovascular disease: Friend or foe?	29
Right ventricular strain in Fabry disease: Prognostic implications	29
Acute heart failure admission and outcome: A single centre contemporary appraisal	29
Burden of Rheumatic Heart Disease as a Barometer of Effective Policy Implementation	29
Mortality after catheter ablation of structural heart disease related ventricular tachycardia	29
Complete electrical reverse remodeling of native conduction after resynchronization therapies	28
The use of bisoprolol in treatment for heart failure and its effects of dose titration on blood pressure and heart rate	28
Assessment of the left atrial volume and function following percutaneous mitral balloon valvuloplasty: Insights into acute and late impact of atrial fibrillation on atrial remodeling	28
Editorial Board	28
Letter to the editor: Prediction of adverse cardiovascular events in children using artificial intelligence-based electrocardiogram	27
Editor's note	27
Clinical implication of hypoalbuminemia in acute heart failure: Insights from Malaysia Heart Failure (MyHF) Registry	27
Targeting the SPP1/TGF-β1 axis in macrophages: A potential therapeutic mechanism for atrial fibrillation?	27
Difficult-to-treat recurrent pericarditis after SARS-CoV-2 vaccination	27
From gatekeeper to game-changer? Rethinking FFRCT in revascularization strategy	27
Domain-specific association of single-nucleotide variants in the LMNA gene with the phenotypic expression of dilated cardiomyopathy	26
Beyond the heart: Mind-body connection from birth and the holistic intervention in cardiovascular care	26
More cardiopulmonary effort testing needed in HFpEF!	26
Plasma expression level of Hsa_circ_0099734 is associated with atrial fibrillation and its poor prognosis	26
Apical ballooning and the rogue clot: A risky affair in Takotsubo syndrome	26
Metabolic disorders as growing risk factors and comorbidities in heart failure	25
Characteristics of patients with suspected cardiac amyloidosis in Tuscany and Umbria: Insights from the cardiac amyloidosis RegistRY (CARRY)	25
Heart failure subphenotypes based on repeated biomarker measurements are associated with clinical characteristics and adverse events (Bio-SHiFT study)	25
Changes of left ventricular remodeling due to increased afterload in patients with essential hypertension	25
Angiography-derived index of microcirculatory resistance as a novel tool to assess coronary microvascular dysfunction in patients with diabetic cardiomyopathy	25
Virtual reality-assisted distraction during transcatheter aortic valve implantation under local anaesthesia: A randomised study	25
Electroanatomical voltage mapping with contact force sensing for diagnosis of arrhythmogenic right ventricular cardiomyopathy	24

Saving time saves lives! A time focused evaluation of a single-view echocardiographic screening protocol for subclinical rheumatic heart disease	24
Signal-morphology impedance cardiography is a non-invasive tool for predicting responses to exercise-based cardiac rehabilitation	24
Heparin dosing in patients with Impella-supported cardiogenic shock	24
Critical aortic stenosis – The long-term burden	24
Functional tricuspid regurgitation: A clustering analysis and prognostic validation of three echocardiographic phenotypes in an external cohort	24
CD163-positive macrophage enrichment in cardiogenic thrombi from atrial fibrillation than in atherosclerotic thrombi from sinus rhythm	24
Prevalence and determinants of tricuspid regurgitation after repair of tetralogy of Fallot	24
Resurrection of classical antiarrhythmic drugs	24
Letter to the editor: “Performance evaluation of four scoring systems for mortality prediction in a contemporary cardiac intensive care unit”	24
Impact of veno-venous collaterals on outcome after the total cavopulmonary connection	24
Precipitating factors in patients with spontaneous coronary artery dissection: Clinical, laboratoristic and prognostic implications	23
Incidence trends and long-term outcomes of myocardial infarction in young adults: Does gender matter?	23
Annular size and interaction with trans-catheter aortic valves for treatment of severe bicuspid aortic valve stenosis: Insights from the BEAT registry	23
Risk score for early risk prediction by cardiac magnetic resonance after acute myocardial infarction	23
Coronary angiography- or fractional flow reserve-guided complete revascularization in multivessel disease STEMI: A Bayesian hierarchical network meta-analysis	23
Periprocedural anticoagulation therapy in patients undergoing micra leadless pacemaker implantation	23
Long-term clinical outcomes in patients with a working diagnosis of myocardial infarction with non-obstructed coronary arteries (MINOCA) assessed by cardiovascular magnetic resonance imaging	23
Optical coherence tomography factors for adverse events in patients with severe coronary calcification	23
Cardiovascular outcomes with SGLT-2 inhibitors in individuals with diabetes and co-existing atrial fibrillation: A systematic review and meta-analysis	23
High low-density lipoprotein cholesterol levels in people with HIV by individual cardiovascular risk: A retrospective observational study	22
Role of speckle tracking echocardiography beyond current guidelines in cardiac resynchronization therapy	22
A novel diagnostic model for fetal coarctation of the aorta with ventricular septal defect	22
Utilization rates and heart transplantation outcomes of donation after circulatory death donors with prior cardiopulmonary resuscitation	22
Application of machine learning algorithms in electronic medical records to predict amputation-free survival after first revascularization in patients with peripheral artery disease	22
A hybridization of XGBoost machine learning model by Optuna hyperparameter tuning suite for cardiovascular disease classification with significant effect of outliers and heterogeneous training dataset	21
Clinical outcomes, management, healthcare resource utilization, and cost according to the CHA2DS2-VASc scores in Asian patients with nonvalvular atrial fibrillation	21
Left atrial strain is associated with arrhythmia recurrence after atrial fibrillation ablation: Cardiac magnetic resonance rapid strain vs. feature tracking strain	21
Effect of PCSK9 antibodies on coronary plaque regression and stabilization derived from intravascular imaging in patients with coronary artery disease: A meta-analysis	21
Temporal progression of replacement and interstitial fibrosis in optimally managed dilated cardiomyopathy patients: A prospective study	21
Mortality trend of ischemic heart disease (2008–2022): A retrospective analysis of epidemiological data	21
Innate and adaptive immunity in acute myocarditis	21
Pericardium, epicardial adipose tissue, and heart failure with preserved ejection fraction: Pathophysiology, quantification and treatment target	21
Swiss Evaluation Registry for Pediatric Infective Endocarditis (SERPIE) - Risk factors for complications in children and adolescents with infective endocarditis	21
Supra-renal aortic atheroma extent and composition predict acute kidney injury after transcatheter aortic valve replacement: A three-dimensional computed tomography study	20
Is primary PCI failing women? An 8-year retrospective study evaluating gender effects on 30-day mortality in ST elevation myocardial infarction	20
Corrigendum to “Potential of68Ga-FAPI-04 PET/MR to predict worsening renal function after acute ST-elevation myocardial infarction” [International journal of cardiology vol. 414 (2024): 132425]	20
Left atrial strain and risk of atrial fibrillation after coronary artery bypass-grafting	20
Could interleukin-1 receptor antagonist be a reliable predictor of prognosis in acute myocardial infarction?	20
Oral health behavior associated with cardiometabolic outcomes: A nationally representative cross-sectional study in Portugal	20
Intervention needs assessment in children with heart diseases presenting to Tibebe-Ghion Specialized Teaching Hospital, Bahir Dar, North West Ethiopia – Tip of the iceberg of the intervention gap in L	20
Corrigendum to “Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine” [International Journal of Cardiology Volume 418, 1 January 2025, 132663]	20
Inadequate Intensification of LDL-cholesterol lowering therapy after coronary revascularization: Insights from the GOULD registry	20
An age-centric evaluation of heart failure management: A comparative study in Sarawak	20
Effect of beta-blockers and angiotensin receptor blockers in reducing the aortic growth rate in children with bicuspid aortic valve-related aortopathy	20
Reply to: Kavsak et al. The clinical chemistry score (CCS) achieves the highest efficacy when assessed with the 99% sensitivity benchmark for myocardial infarction	20
Editorial Board	20
Age-related changes in clinical characteristics and outcomes of chronic heart failure outpatients in a cardiology setting. A report from the Italian Network on Heart Failure	19
Genetic association between inflammatory factors and abdominal aortic calcification: Insights from a genome-wide association study	19
Subclinical myocardial work impairment in non-diabetic overweight and obese individuals: Impact of cardiometabolic traits	19
Sex- specific differences in suspected myocarditis presentations and outcomes	19
Poor tooth brushing behavior is associated with high risk of cardiovascular events: A prospective observational study	19
Heart failure with preserved ejection fraction in atrial functional mitral regurgitation – Insight from the REVEAL-AFMR	19
A hybrid machine learning approach using particle swarm optimization for cardiac arrhythmia classification	19
Letter to “Non-vitamin K antagonist oral anticoagulants (NOACs) and risk of spontaneous intracranial hemorrhage in patients with ischemic stroke: An analysis using Taiwan’s National Health Insurance R	19
Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study	19
MicroRNA-29b regulates pyroptosis involving calcific aortic valve disease through the STAT3/SOCS1 pathway	19
Unveiling the link between plasma proteome and cardiac function: A leap forward in heart failure research	18
Biomarkers in paroxysmal atrial fibrillation during an acute episode: The cause or the result?	18
The CNIC polypill (Acetylsalicylic acid + Atorvastatin + Rampril) in secondary prevention of cardiovascular disease in patients with type 2 diabetes: A comparative analysis with alternative therapeuti	18
Educational tools may turn into decision-making strategies in clinical practice – The case of primary percutaneous coronary intervention risk scores	18
Catheter ablation versus medical therapy for atrial fibrillation- single centre, retrospective study	18
The authors' reply to the letter “CA125 a cause or an effect in heart failure?”	18
Single-pill combination in the management of chronic coronary syndromes: A strategy to improve treatment adherence and patient outcomes?	18
Hemodynamic effects of balloon pulmonary angioplasty for the treatment of total and subtotal pulmonary artery occlusions in inoperable chronic thromboembolic pulmonary hypertension	18
Pre-procedural oral anticoagulant use is associated with cardiovascular events in women after transcatheter aortic valve replacement: An analysis from the WIN-TAVI cohort	18
Clinical relevance of coronary microvascular dysfunction following rotational Atherectomy	18
Is anion gap helpful for assessing cardiovascular risk in cardiac intensive care unit?	18
High bleeding risk (HBR) in contemporary percutaneous coronary intervention (PCI) Malaysian Cohort	18
Characteristics of patients with intradialytic hypotension in North Kuala Lumpur and the prevalence of coronary artery disease among them	18
Safety and efficacy of renal denervation (RDN) in treatment of resistant hypertension: A single centre, 1 year observational study	18
Outcomes of the Qatar Transcatheter aortic valve implantation- registry (QATAVI-registry) –first report 24/7/2024	18
P 031: Successful treatment of radiation pericarditis with corticosteroid	18
The association of inflammatory biomarkers and long-term clinical outcomes in older adults with non-ST elevation acute coronary syndrome	18
Letter to the editor: Physical activity characteristics in adults with bicuspid aortic valve versus age and sex matched controls	18
Benefits of cardiac rehabilitation on cardiovascular outcome in patients post acute coronary syndrome	18
Cell-free long noncoding RNAs as predictive biomarkers for cardiovascular diseases	18
Small coronary artery matters: Non-dominant right coronary artery and perfusion imaging	18
Isolated tricuspid valve surgery: The devil is infective endocarditis?	17
Atrial-FMR: No longer the forgotten mechanism of functional mitral regurgitation	17
Quality of anticoagulation control among patients receiving vitamin K antagonist in pharmacist-managed anticoagulation medication therapy adherence clinic	17

Postprocedural Radial Artery Compression Time In Chronic AnticoaguLated patients using StatSeal: The PRACTICAL-SEAL study	17
P 004: As subtle as it can be-OMI paradigm, another myocardium saved	17
REACHing conclusions on the external applicability of the THEMIS into clinical practice	17
Erratum to “Chemokine-like receptor 1 deficiency impedes macrophage phenotypic transformation and cardiac repair after myocardial infarction” [International Journal of Cardiology 372C (2023) 6–14]	17
Navigating upstream and downstream: Unleashing the prognostic potential of RVFWLS/PASP ratio in severe tricuspid regurgitation	17
No effect of remoteness on clinical outcomes following myocardial infarction: An analysis of 43,729 myocardial infarctions in Victoria, Australia	17
Procedural setting of percutaneous coronary intervention in Malaysia during the SARS-COV-2 pandemic – data from The National Heart Association of Malaysia's NCVD-PCI Registry	17
Prevalence and characteristics of transesophageal echocardiography-related esophageal mucosal injury in patients with atrial fibrillation who underwent pulmonary vein isolation	17
Ten-year outcomes post percutaneous coronary intervention in cardiac transplant recipients	17
Spontaneous coronary artery dissection and ST-segment elevation myocardial infarction: Does clinical presentation matter?	17
Lessons from rare cardiomyopathies: The importance of a phenotype-based approach to arrive at a specific diagnosis	17
Supported PCI reduced one-year all-cause mortality compared to standard PCI?	17
HOTAIR functions as a ceRNA to aggravate myocardial fibrosis through the miR-141/wnt5a axis	17
How cardiologists can manage excess body weight and related cardiovascular risk. An expert opinion	17
Targeting NEAT1 in heart disease	17
LncRNA TUG1 regulates autophagy in atherosclerosis by sponging miR-145-5p	17
Editorial Board	17
Percutaneous coronary intervention from COURAGE to ISCHEMIA and beyond	17
Editorial Board	17
Clinical impact of multiple resheathing during transcatheter aortic valve implantation with Evolut self-expanding valves	16
Worsening tricuspid regurgitation after mitral valve surgery: a meta-analysis and meta-regression	16
The miR-26b/CTGF axis: A promising therapeutic mechanism for managing myocardial fibrosis post myocardial infarction	16
Prognostic value of CMR-derived ECV in MINOCA patients: Progress and remaining challenges	16
Favorable impact of FFRCT on myocardial revascularization outcomes: Results from an observational real-world registry	16
Reply to “Letter to the editor: Incidence of de novo malignancy and all-cause mortality among heart transplant recipients”	16
Impact of sex on Transcatheter aortic valve replacement outcomes: Results of a single-center study	16
Impact of hospitalisation burden on mortality in adult congenital heart disease: A nationwide population study	16
Monitoring and treatment of hypercholesterolemia after an atherosclerotic cardiovascular disease event in Denmark from 2015 to 2020	16
Multimodality imaging in arrhythmogenic cardiomyopathy - From diagnosis to management	16
Aerobic fitness change with time in children with congenital heart disease: A retrospective controlled cohort study	16
Letter to the editor: Utilization rates and determinants of PYP and CMR among patients with unexplained left ventricular hypertrophy on echocardiography	16
Precision medicine in the treatment of STEMI patients – it's time for coronary physiology!	16
Echocardiographic detection of heart valve disease in a community cohort of asymptomatic Australians > 65 years with cardiovascular risk factors	16
Mode of death and outcomes of implantable cardioverter defibrillators in transthyretin amyloid cardiomyopathy	16
Exercise capacity following SARS-CoV-2 infection is related to changes in cardiovascular and lung function in military personnel	16
Left ventricular assist device in the presence of subcutaneous implantable cardioverter defibrillator: Data from a multicenter experience	16
Reply to ‘unveiling the link between plasma proteome and cardiac function: A leap forward in heart failure research’	16
Editorial Board	16
Editorial Board	16
Characteristics, management, and mid-term prognosis of older adults with cardiogenic shock admitted to intensive care units: Insights from the FRENSHOCK registry	16
Multivessel revascularization in non-ST segment elevation acute coronary syndromes: A systematic review and meta-analysis of 182,798 patients	15
Healthcare costs in implantable cardioverter-defibrillator recipients: A real-life cohort study on 19,408 patients from the French national healthcare database	15
Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine	15
Psychosocial distress and health status as risk factors for ten-year major adverse cardiac events and mortality in patients with non-obstructive coronary artery disease	15
The [99mTc]Tc-HMPAO-labelled white blood cell SPECT/CT as a novel criterion for infective endocarditis diagnosis	15
Effectiveness of Vericiguat on right ventricle to pulmonary artery uncoupling associated with heart failure with reduced ejection fraction	15
Left atrial function's evaluation in aortic stenosis: A clinical imperative	15
Editorial Board	15
Comparative evaluation of standard maintenance-dose clopidogrel versus low-dose prasugrel in patients with stable coronary artery disease after percutaneous coronary intervention	15
The real-world safety of sacubitril / valsartan among older adults (≥75): A pharmacovigilance study from the FDA data	15
Addressing the unmet needs of cardiovascular evaluation in athletes: A national survey of the Italian Society of Cardiology (SIC) and the Regional Associations of Ambulatory Cardiologists (ARCA)	15
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy	15
Associations of cardiac function and arterial stiffness with cerebrovascular disease	15
Low-dose colchicine and high-sensitivity C-reactive protein after myocardial infarction: A combined analysis using individual patient data from the COLCOT and LoDoCo-MI studies	15
Do SGLT2 inhibitors protect elderly patients from HF rehospitalization and CKD progression? More opportunities than concerns	15
Coronary calcifications are the growth rings of coronary atherosclerotic plaque	15
Temporal variations in ischemic and bleeding event risks after acute coronary syndrome during dual antiplatelet therapy	15
Acute coronary syndromes in young patients: Phenotypes, causes and clinical outcomes following percutaneous coronary interventions.	15
Clinical characteristics, management, diagnostic findings, and various etiologies of patients with Kounis syndrome. A systematic review	15
ST Elevation is a poor surrogate for acute coronary occlusion. Let's Replace STEMI with Occlusion MI (OMI)!!	15
High-sensitivity C-reactive protein, plaque vulnerability and adverse events in patients with stable coronary disease: An optical coherence tomography study	15
Patterns of aortic valve replacement in Europe and adoption by sex	15
Left ventricular morphologic progression in apical hypertrophic cardiomyopathy	15
A simplified echocardiographic formula to estimate cardiac index in the intensive care unit	15
Trends in mechanical circulatory support utilization, left ventricular assist device implantation and transplant during cardiogenic shock hospitalizations, after the new heart allocation policy	15
Dynamic glycemic monitoring and systemic inflammation assessment: New insights into plaque characteristics in acute myocardial infarction	14
Impact of radiofrequency versus cryoballoon ablation on left atrial calcification after atrial fibrillation ablation: A propensity score-matched comparison	14
A retrospective study: Long term prognosis in adults with PA-VSD-MAPCAs	14
Cardiopulmonary exercise testing: Time to rethink the validity of non-metabolic thresholds?	14
Diagnosing HCM severity: The role of microvascular impairment	14
Neo 2 transcatheter heart valve system: Direct towards a minimalistic procedure	14
Head-up tilt testing in patients with suspected vasovagal syncope: A meta-regression modelling	14
Impact of comorbidity on complication rates and life expectancy in patients with a leadless pacemaker	14
Exercise response in post-acute coronary syndrome patients survived to COVID-19 infection	14
Precision targeting of PERK in ischemia/reperfusion: Unresolved temporal dynamics and lipid transport mechanisms	14
Glycemic control and coronary plaque characteristics in patients with acute myocardial infarction	14
Efficacy of beta-blocker therapy in Takotsubo cardiomyopathy: Insights from a systematic review and meta-analysis	14
Response to the editorial “Beyond the heart: Mind-body connection from birth and the holistic intervention in cardiovascular care”	14
Right ventricular pacing during TAVR: Make the things as simple as possible but not simpler	14
Conduction disturbances after TAVR with newer-generation self-expanding valves	14
Identification of echocardiographic subgroups in patients with coronary heart disease combined with heart failure based on latent variable stratification	14
Reply to Commentary on “Relationship between coronary artery calcification and plaque vulnerability, a qualitative and quantitative optical coherence tomography study”	14
MINOCA in Men and Women: Different Conditions and a Single Destiny?	14
Reply to “Growth differentiation factor 15 and empagliflozin in acute myocardial infarction: Correspondence”	14
Shiny curves, shaky foundations: Bias and reliability in no-reflow prediction models	14
Endeavor of exploring mechanisms of myocardial infarction in patients with no standard modifiable cardiovascular risk factors	14
Left atrial strains in cardiac amyloidosis -does its subtype matter?	14
Editorial Board	14
Antiplatelet therapy in percutaneous coronary intervention: Can we expect a revival of the use of parenteral agents?	14
Machine learning-based prediction of infarct size in patients with ST-segment elevation myocardial infarction: Misinterpretation	14
Insights of upregulating of DDAH2 expression by pharmacological action	14
Reappraising the role of MAFLD in myocardial strain: The importance of infarct burden and fibrosis phenotype	14
Predicting prolonged length of in-hospital stay in patients with non-ST elevation myocardial infarction (NSTEMI) using artificial intelligence	14
Takotsubo syndrome: Its variants, and recent additions to our knowledge	14
Sex-specific disparities in catheter-directed therapies for pulmonary embolism	14